Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DUT | P33316 | 2/20 | 0.52 |
| ▸ | P2RY2 | P41231 | 16/20 | 0.49 |
| ▸ | P2RY4 | P51582 | 10/20 | 0.49 |
| ▸ | POLA1 | P09884 | 1/20 | 0.47 |
| ▸ | P2RY6 | Q15077 | 6/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL986334 | 0.90 | DUT (0.52) | DUTP2RY2P2RY4P2RY6 | |
| SCHEMBL1129336 | 0.88 | DUT (0.52) | DUTP2RY2P2RY4POLA1P2RY6 | |
| SCHEMBL7745800 | 0.88 | DUT (0.55) | DUTP2RY2P2RY4POLA1P2RY6 | |
| SCHEMBL8441083 | 0.88 | DUT (0.52) | DUTP2RY2P2RY4POLA1P2RY6 | |
| SCHEMBL16670190 | 0.87 | DUT (0.51) | DUTP2RY2P2RY4POLA1P2RY6 | |
| SCHEMBL8439797 | 0.87 | DUT (0.51) | DUTP2RY2P2RY4POLA1P2RY6 | |
| SCHEMBL1129230 | 0.86 | DUT (0.54) | DUTP2RY2P2RY4POLA1P2RY6 | |
| SCHEMBL14855438 | 0.86 | DUT (0.50) | DUTP2RY2P2RY4POLA1P2RY6 | |
| SCHEMBL8436034 | 0.86 | DUT (0.52) | DUTP2RY2P2RY4POLA1P2RY6 | |
| SCHEMBL8441386 | 0.84 | DUT (0.51) | DUTP2RY2P2RY4POLA1P2RY6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 210 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7087375-B1 | Method for determining the mechanism of HIV RT inhibitors | VIRCO, N.V. (BE) | 2006-08-08 | — | — | US | claimed |
| EP-3921440-B1 | METHOD AND PRODUCTS FOR PRODUCING FUNCTIONALISED SINGLE STRANDED OLIGONUCLEOTIDES | MOLIGO TECH AB (SE) | 2024-03-27 | — | — | EP | disclosed |
| CN-117377774-A | Method for sensitive analyte detection and kit therefor | 卡维迪有限公司 | 2024-01-09 | — | — | CN | disclosed |
| US-20230079822-A1 | METHOD AND PRODUCTS FOR PRODUCING SINGLE STRANDED DNA POLYNUCLEOTIDES | MOLIGO TECHNOLOGIES AB (SE) | 2023-03-16 | — | — | US | disclosed |
| EP-4110914-A1 | METHOD AND PRODUCTS FOR PRODUCING SINGLE STRANDED DNA POLYNUCLEOTIDES | Moligo Technologies AB (SE) | 2023-01-04 | — | — | EP | disclosed |
| CN-109868309-B | Single-stranded DNA amplification method based on universal base substitution insertion | 苏州恩可医药科技有限公司 | 2022-11-11 | — | — | CN | disclosed |
| CN-109852727-B | HBV-cccDNA detection method and kit based on universal base substitution insertion | 苏州恩可医药科技有限公司 | 2022-10-11 | — | — | CN | disclosed |
| EP-1583843-B1 | SINGLE PRIMER WHOLE GENOME AMPLIFICATION | QIAGEN GMBH (DE) | 2018-07-18 | — | — | EP | disclosed |
| EP-3294326-A1 | PRIME-BOOST REGIMENS INVOLVING ADMINISTRATION OF AT LEAST ONE MRNA CONSTRUCT | CureVac AG (DE) | 2018-03-21 | — | — | EP | disclosed |
| US-9593366-B2 | Individually synthesized primers to be used in whole genome amplification | QIAGEN GAITHERSBURG, INC. (US) | 2017-03-14 | — | — | US | disclosed |
| US-5549711-A | Prosthetic foot and keel therefor having progressive stiffening under increasing load | M+IND (MODEL + INSTRUMENT DEVELOPMENT) (US) | 1996-08-27 | — | — | US | disclosed |
| EP-0720456-A1 | PROSTHETIC FOOT AND KEEL THEREFOR HAVING PROGRESSIVE STIFFENING UNDER INCREASING LOAD | M+IND (Model + Instrument Development) (US) | 1996-07-10 | — | — | EP | disclosed |
| EP-0686202-A1 | PRENATAL SCREENING | BRANDEIS UNIVERSITY (US) | 1995-12-13 | — | — | EP | disclosed |
| WO-1995008967-A1 | PROSTHETIC FOOT AND KEEL THEREFOR HAVING PROGRESSIVE STIFFENING UNDER INCREASING LOAD | M+IND (MODEL + INSTRUMENT DEVELOPMENT) (US) | 1995-04-06 | — | — | WO | disclosed |
| WO-1994018344-A1 | PRENATAL SCREENING | BRANDEIS UNIVERSITY (US) | 1994-08-18 | — | — | WO | disclosed |
| EP-0417161-A4 | SOLID-PHASE SEQUENCING METHOD FOR SINGLE- AND DOUBLE-STRANDED NUCLEIC ACIDS | — | 1992-08-12 | — | — | EP | disclosed |
| EP-0417161-A1 | SOLID-PHASE SEQUENCING METHOD FOR SINGLE- AND DOUBLE-STRANDED NUCLEIC ACIDS | APPLIED BIOSYSTEMS, INC. (US) | 1991-03-20 | — | — | EP | disclosed |
| WO-1990001562-A1 | SOLID-PHASE SEQUENCING METHOD FOR SINGLE- AND DOUBLE-STRANDED NUCLEIC ACIDS | APPLIED BIOSYSTEMS, INC. (US) | 1990-02-22 | — | — | WO | disclosed |
| WO-1985002415-A1 | NON RADIOACTIVE PROBE AND PROCESS FOR THE CHARACTERIZATION OF A DTERMINED NUCLEOTIDE SEQUENCE AND MEANS FOR THE PRODUCTION OF SAID NON RADIOACTIVE PROBE | INSTITUT PASTEUR (FR) | 1985-06-06 | — | — | WO | disclosed |
| EP-0143059-A1 | Non-radioactive probe and process for the characterization of a particular nucleotide sequence, and means for the production of this non-radioactive probe | INSTITUT PASTEUR (FR) | 1985-05-29 | — | — | EP | disclosed |